BenzingaAugust 6, 2026 at 12:21 PM NY29 days ago
Cerence Narrows FY2026 GAAP EPS Guidance from $(0.07)-$0.15 to $(0.02)-$0.06 vs $0.03 Est; Narrows FY2026 Sales Guidance from $305.000M-$320.000M to $310.000M-$314.000M vs $315.340M Est
Cerence (NASDAQ:CRNC) narrows FY2026 GAAP EPS guidance from $(0.07)-$0.15 to $(0.02)-$0.06 vs $0.03 analyst estimate. Narrows FY2026 sales outlook from $305.000 million-$320.000 million to $310.000 million-$314.000
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site — Benzinga
Companies in This Story
Related Stories
The trading volume of these stocks is deviating from the norm in today's session.
ChartMill1 hour ago
Discover which S&P500 stocks are making waves on Friday.
ChartMill2 hours ago
Sodexo : Monthly disclosure on share capital and voting rights August 31, 2026
Yahoo3 hours ago
ANF vs. TPR: Which Stock Is the Better Value Option?
Yahoo3 hours ago
Anthropic's IPO Push Just Got a $15 Billion Backstop
Yahoo3 hours ago